ARCHIVES

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

This article is from The Cancer Letter archive.

Vol. 35 No. 5 | May 25, 2012

Download PDF Visit The Full Archive

Related Articles

Capitol Hill: Groups Warn Of Harm From Bill To Promote Breast Self-Exams

May 29, 2009

The 99th turned Out Well For Cancer Program, But Several Important Issues Await 100th Congress

October 31, 1986

Center Directors Urge NCI To Expand CTEP’s Treatment Referral Cntr.

March 12, 1993

In Brief: Wells, Gardner, Brennan Lead Surgical Oncology; Young, Flynn, Are New officers For Head & Neck

March 26, 1993

In Brief: Cancer Panel to Meet Sept. 30 In Boston; House Passes Money Bill, With 41.347 Billion For NCI

August 15, 1986

Modeling Will Be Used For Other Populations

November 26, 2010